St. Jude Medical Receives FDA and CE Mark Approvals for the World's Smallest, Longest-Lasting Rechargeable ... (Centre Daily Times)
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of Eon Mini((TM)), the world's smallest, longest-lasting rechargeable neurostimulator to treat chronic pain of the trunk or limbs and pain from failed back surgery.

Relying 'Solely' On FDA To Judge Safety Of Ortho Evra Patch Is A Mistake, Editorial Says (Medical News Today)
It would be a mistake to "rely solely" on FDA to judge the safety and efficacy of the birth control patch Ortho Evra, a New York Times editorial says. The editorial notes that the agency is short of skilled scientists and might not detect or appreciate the significance of important information buried "deep in the bowels" of a report (New York Times, 4/14).

Neoprobe Receives $3 Million in Clinical Funding (Centre Daily Times)
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that concurrent with the authorization by FDA to commence patient enrollment in a Phase 3 multi-center clinical study of Lymphoseek, the Company completed the second closing of $3 million in financing committed to by Platinum-Montaur Life ...